CRGO (NASDAQ: CRGO) director Zvi Schreiber records multiple share sales

Rhea-AI Filing Summary

CRGO filing under Rule 144 lists proposed and completed dispositions of ordinary shares by Zvi Schreiber and shows restricted stock units scheduled for issuance. The filing documents 30,699 and 2,000 Restricted Stock Units with grant dates 09/06/2023 and 02/15/2024. It also records multiple sales by Zvi Schreiber, including 25,000 shares sold on 05/15/2026 for $52,500.

Insights

Equity Compensation Analyst

Filing lists scheduled RSU awards and a sequence of recent sales by a named holder.

The excerpt enumerates 30,699 Restricted Stock Units granted on 09/06/2023 and 2,000 RSUs granted on 02/15/2024, and shows multiple share dispositions by Zvi Schreiber, including a 25,000-share sale on 05/15/2026 for $52,500.

These entries record issuance schedules and downstream sales activity; subsequent filings would show whether the RSUs convert to additional shares or affect outstanding counts. Transaction timing and holding-period compliance are matters for counsel and transfer agents.

Key Figures

RSUs granted: 30,699 shares RSUs granted: 2,000 shares Sale example: 25,000 shares +2 more

5 metrics

RSUs granted 30,699 shares Restricted Stock Units granted on 09/06/2023

RSUs granted 2,000 shares Restricted Stock Units granted on 02/15/2024

Sale example 25,000 shares Sold on 05/15/2026 for <money>$52,500</money>

Sale example 20,000 shares Sold on 05/11/2026 for <money>$41,017.45</money>

Sale example 20,000 shares Sold on 05/06/2026 for <money>$41,000.00</money>

Key Terms

Restricted Stock Units, Rule 144, Ordinary

3 terms

Restricted Stock Units financial

"Restricted Stock Units | Issuer | 30699 | 09/06/2023"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Rule 144 regulatory

"144: Securities To Be Sold"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Ordinary financial

"Ordinary | Oppenheimer& Co. Inc 85 Broad St."

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Ordinary	Oppenheimer& Co. Inc 85 Broad St. New York NY 10004	7699	15782.95	51376890	05/19/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Ordinary	09/06/2023	Restricted Stock Units	Issuer			30699	09/06/2023	N/A
Ordinary	02/15/2024	Restricted Stock Units	Issuer			2000	02/15/2024	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Zvi Schreiber PLANTA 10, AVDA. DIAGONA BARCELONA U3 08018	Ordinary	05/11/2026	20000	41017.45
Zvi Schreiber PLANTA 10, AVDA. DIAGONA BARCELONA U3 08018	Ordinary	05/15/2026	25000	52500.00
Zvi Schreiber PLANTA 10, AVDA. DIAGONA BARCELONA U3 08018	Ordinary	05/06/2026	20000	41000.00
Zvi Schreiber PLANTA 10, AVDA. DIAGONA BARCELONA U3 08018	Ordinary	05/04/2026	20000	41000.00
ZVI SCHREIBER PLANTA 10, AVDA. DIAGONA BARCELONA U3 08018	Ordinary	04/28/2026	15000	30750.00
ZVI SCHREIBER PLANTA 10, AVDA. DIAGONA BARCELONA U3 08018	Ordinary	04/17/2026	10000	21300.00
ZVI SCHREIBER PLANTA 10, AVDA. DIAGONA BARCELONA U3 08018	Ordinary	04/15/2026	10000	18500.00
ZVI SCHREIBER PLANTA 10, AVDA. DIAGONA BARCELONA U3 08018	Ordinary	04/13/2026	10000	16200.00
ZVI SCHREIBER PLANTA 10, AVDA. DIAGONA BARCELONA U3 08018	Ordinary	04/08/2026	10000	16900.00
ZVI SCHREIBER PLANTA 10, AVDA. DIAGONA BARCELONA U3 08018	Ordinary	04/01/2026	5000	8200.00
ZVI SCHREIBER PLANTA 10, AVDA. DIAGONA BARCELONA U3 08018	Ordinary	03/30/2026	5000	8150.00
ZVI SCHREIBER PLANTA 10, AVDA. DIAGONA BARCELONA U3 08018	Ordinary	03/24/2026	10000	15850.00
ZVI SCHREIBER PLANTA 10, AVDA. DIAGONA BARCELONA U3 08018	Ordinary	03/17/2026	10000	16508.50
ZVI SCHREIBER PLANTA 10, AVDA. DIAGONA BARCELONA U3 08018	Ordinary	03/16/2026	10000	15214.04
ZVI SCHREIBER PLANTA 10, AVDA. DIAGONA BARCELONA U3 08018	Ordinary	03/11/2026	5000	6300.00

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What RSU grants does CRGO list in this Rule 144 filing?

The filing lists 30,699 Restricted Stock Units with grant date 09/06/2023 and 2,000 RSUs with grant date 02/15/2024. These figures appear under the securities to be sold section.

Who sold shares recently according to the CRGO filing?

The filing reports multiple sales by Zvi Schreiber, including a 25,000-share sale on 05/15/2026 for $52,500. Several other dates and amounts are listed in the sales table.

How many shares were sold on 05/11/2026 in the CRGO filing?

On 05/11/2026 the filing shows a sale of 20,000 Ordinary shares for $41,017.45. This is one entry among multiple recent dispositions by the same holder.

Does the filing state who is the broker or market for the sales?

The excerpt identifies a broker address for Oppenheimer & Co. Inc. but does not link a specific sales method to each transaction. Broker details appear near the securities header.